Fundstrat Granny Shots US Small- and Mid-Cap ETF (GRNJ)
Live price chart, market sentiment, and community perspectives for Fundstrat Granny Shots US Small- and Mid-Cap ETF (AMEX: GRNJ).
Live price chart, market sentiment, and community perspectives for Fundstrat Granny Shots US Small- and Mid-Cap ETF (AMEX: GRNJ).
On our desk, the institutional accumulation in GRNJ is hard to ignore. Seeing 77 hedge funds and large institutions pile in with $289M during Q2 2026—plus 22 new positions opened—shows that Tom Lee's thematic branding carries weight. We like how the equal-weighted portfolio rebalances quarterly to capture structural themes like PMI recovery, Millennials, and Easing Financial Conditions without letting a single mega-cap small cap distort the basket.
Watching the 50-day MA and recent price action down at $29.38, I'm noting the massive 68.1% drop in short interest in July. When short interest evaporates that fast on a mid-cap basket, it usually points to either a structural change in how shorts view the fund or an aggressive de-risking phase. We are maintaining a close eye on the stop loss parameters before committing fresh capital here.
From a quantitative risk perspective, the core strategy relies heavily on multi-factor alignment: any stock must match at least two thematic pillars to stay eligible. When reviewing positions like ALB, ALLY, and AVAV during the February rebalance, the equal-weighting mechanism forces continuous re-allocation. You have to ensure your risk models account for sector drift every single quarter.
Looking closely at the semi-annual shareholder reports and investor decks published through May and June 2026, the transparency around quarterly rebalance notifications is top-tier. Knowing exactly how holdings shift across cybersecurity, labor suppliers, and seasonality themes gives our research team the exact data points needed to map out our quarterly factor exposures.
As a risk manager, the trajectory from its initial launch up to $384 million in AUM is impressive, but the current market cap hovering around $537M with a share price near $29.93 means we need strict stop-loss rules. Danelfin's AI score tracking and 3-month horizon parameters provide a helpful quantitative guardrail against sudden drawdowns in small-cap volatility.
Explore plasma cleansing, somatic organ swaps, and BCI.